These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 19197233

  • 1. Two new drugs for chronic ITP.
    Med Lett Drugs Ther; 2009 Feb 09; 51(1305):10-1. PubMed ID: 19197233
    [Abstract] [Full Text] [Related]

  • 2. Orphan disease gains second treatment option.
    Morrow T.
    Manag Care; 2009 Jan 09; 18(1):47-9. PubMed ID: 19186672
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.
    Am J Hematol; 2016 May 09; 91(5):E293-5. PubMed ID: 26910388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.
    J Clin Pharm Ther; 2012 Dec 09; 37(6):729-32. PubMed ID: 22583038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infection-related transient loss of response and other early side effects in chronic ITP during treatment with thrombopoietin mimetics.
    Meyer O, Salama A.
    Onkologie; 2011 Dec 09; 34(1-2):10-3. PubMed ID: 21346379
    [Abstract] [Full Text] [Related]

  • 11. Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.
    Al-Samkari H, Kuter DJ.
    Br J Haematol; 2018 Oct 09; 183(2):168. PubMed ID: 29978577
    [No Abstract] [Full Text] [Related]

  • 12. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.
    Kuter DJ, Macahilig C, Grotzinger KM, Poston SA, Wang PF, Dawson KL, Ward M.
    Int J Hematol; 2015 Mar 09; 101(3):255-63. PubMed ID: 25586660
    [Abstract] [Full Text] [Related]

  • 13. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.
    Neunert CE, Rose MJ.
    Blood Adv; 2019 Jun 25; 3(12):1907-1915. PubMed ID: 31239245
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sustaining platelet counts in chronic ITP.
    Nurden AT.
    Lancet; 2011 Jan 29; 377(9763):358-60. PubMed ID: 20739056
    [No Abstract] [Full Text] [Related]

  • 16. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M, Kato M, Koh K, Hanada R.
    Rinsho Ketsueki; 2015 May 29; 56(5):511-3. PubMed ID: 26062675
    [Abstract] [Full Text] [Related]

  • 17. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
    Vadhan-Raj S.
    Semin Hematol; 2009 Jan 29; 46(1 Suppl 2):S26-32. PubMed ID: 19245931
    [Abstract] [Full Text] [Related]

  • 18. Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice.
    Ptushkin VV, Vinogradova OY, Pankrashkina MM, Chernikov MV, Arshanskaya EG, Tkachenko NE.
    Ter Arkh; 2018 Aug 17; 90(7):70-76. PubMed ID: 30701925
    [Abstract] [Full Text] [Related]

  • 19. Eltrombopag. Idiopathic thrombocytopenic purpura after treatment failure: romiplostim is a better option.
    Prescrire Int; 2010 Feb 17; 19(105):15. PubMed ID: 20455333
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoids promote response to thrombopoietin-receptor agonists in refractory ITP: a case series.
    Poston JN, Gernsheimer TB.
    Int J Hematol; 2019 Aug 17; 110(2):255-259. PubMed ID: 30972617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.